Medical Devices Rules Amended to Include European Union Countries in Rule 63
Posted by: Prabhas Chakraborty September 8, 2026
Read More
CDSCO
CDSCO
Government Proposes Inclusion of Four Additional Drugs in Schedule H1
Posted by: Prabhas Chakraborty September 3, 2026
Read MoreMedical Devices (Second Amendment) Rules, 2026: New Sterilization Labelling Requirements and Testing Fees
Posted by: Hitesh Gupta August 31, 2026
Read MoreICMR and CDSCO Invite Stakeholder Comments on Standard IVD Performance Evaluation Protocols for Scrub Typhus
Posted by: Prabhas Chakraborty August 24, 2026
Read MoreClarification on the submission of applications for grant of Permission to Import and Market New Drugs not approved anywhere in the world, wherein Phase III Global Clinical Trials (GCT) are ongoing or completed with participation of Indian subjects under the New Drugs and Clinical Trials Rules, 2019
Posted by: Hitesh Gupta August 13, 2026
Read More- 7
- Comments Off on Clarification on the submission of applications for grant of Permission to Import and Market New Drugs not approved anywhere in the world, wherein Phase III Global Clinical Trials (GCT) are ongoing or completed with participation of Indian subjects under the New Drugs and Clinical Trials Rules, 2019
- 13th August, 2026
Amendment to Rule 89 of the Drugs Rules, 1945 for obtaining licence under Form 29 for additional manufacturing licence categories
Posted by: Hitesh Gupta August 13, 2026
Read MoreDebarment of Applicants Submitting Misleading, Fake, or Fabricated Documents under the Drugs Rules, 1945
Posted by: Hitesh Gupta August 10, 2026
Read More